| The bone marrow microenvironment at single-cell resolution AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ... Nature 569 (7755), 222-228, 2019 | 760 | 2019 |
| Restoration of TET2 function blocks aberrant self-renewal and leukemia progression L Cimmino, I Dolgalev, Y Wang, A Yoshimi, GH Martin, J Wang, V Ng, ... Cell 170 (6), 1079-1095. e20, 2017 | 649 | 2017 |
| Killing cells by targeting mitosis E Manchado, M Guillamot, M Malumbres Cell Death & Differentiation 19 (3), 369-377, 2012 | 270 | 2012 |
| Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α, δ phosphatase E Manchado, M Guillamot, G de Cárcer, M Eguren, M Trickey, ... Cancer cell 18 (6), 641-654, 2010 | 225 | 2010 |
| MED12 regulates HSC-specific enhancers independently of mediator kinase activity to control hematopoiesis B Aranda-Orgilles, R Saldaña-Meyer, E Wang, E Trompouki, A Fassl, ... Cell stem cell 19 (6), 784-799, 2016 | 117 | 2016 |
| The impact of DNA methylation in hematopoietic malignancies M Guillamot, L Cimmino, I Aifantis Trends in cancer 2 (2), 70-83, 2016 | 89 | 2016 |
| Cdc14b regulates mammalian RNA polymerase II and represses cell cycle transcription M Guillamot, E Manchado, M Chiesa, G Gómez-López, DG Pisano, ... Scientific reports 1 (1), 189, 2011 | 55 | 2011 |
| Regulation of stem cell function by protein ubiquitylation A Strikoudis, M Guillamot, I Aifantis EMBO reports 15 (4), 365-382, 2014 | 53 | 2014 |
| The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation M Guillamot, D Ouazia, I Dolgalev, ST Yeung, N Kourtis, Y Dai, K Corrigan, ... Nature immunology 20 (9), 1196-1207, 2019 | 52 | 2019 |
| The CUL4-DDB1 ubiquitin ligase complex controls adult and embryonic stem cell differentiation and homeostasis J Gao, SM Buckley, L Cimmino, M Guillamot, A Strikoudis, Y Cang, ... Elife 4, e07539, 2015 | 43 | 2015 |
| The impact of inflammation-induced tumor plasticity during myeloid transformation A Yeaton, G Cayanan, S Loghavi, I Dolgalev, EM Leddin, CE Loo, ... Cancer discovery 12 (10), 2392-2413, 2022 | 37 | 2022 |
| TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity T Muto, M Guillamot, J Yeung, J Fang, J Bennett, B Nadorp, A Lasry, ... Cell Stem Cell 29 (2), 298-314. e9, 2022 | 34 | 2022 |
| The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway M Chiesa, M Guillamot, MJ Bueno, M Malumbres Cell Cycle 10 (10), 1607-1617, 2011 | 21 | 2011 |
| Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells C Villarroya‐Beltri, AFB Martins, A García, D Giménez, E Zarzuela, ... The EMBO Journal 42 (1), e111251, 2023 | 8 | 2023 |
| Splicing the innate immune signalling in leukaemia M Guillamot, I Aifantis Nature cell biology 21 (5), 536-537, 2019 | 2 | 2019 |
| Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity M Guillamot, I Subudhi, V Paraskevopoulou, A Prystupa, I Sidhu, ... bioRxiv, 2024.04. 24.590828, 2024 | | 2024 |
| Abstract A20: Inflammation remodels the immune microenvironment in acute myeloid leukemia A Lasry, B Nadorp, M Fornerod, D Nicolet, H Wu, CJ Walker, Z Sun, ... Blood Cancer Discovery 4 (3_Supplement), A20-A20, 2023 | | 2023 |
| Clinical and Pathologic features of North American/Caribbean Adult T-cell leukemia/lymphoma (ATLL), the Brooklyn, NY experience Y Sun, M Guillamot, I Dolgalev, I Aifantis, CA Axiotis Medical Research Archives 9 (10), 2021 | | 2021 |
| Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity T Muto, M Guillamot, J Fang, LZ Redondo, K Choi, Y Gong, CS Walker, ... Blood 134, 727, 2019 | | 2019 |
Marcos MalumbresVall d'Hebron Institute of Oncology在 vhio.net 的电子邮件经过验证
